Combining Low Oxygen Therapy and an Adenosine A2a Receptor Antagonist to Improve Functional Mobility After Spinal Cord Injury

NCT05217498 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Spinal Cord Injuries
Myelopathy

Interventions

DRUG: Istradefylline
DEVICE: low oxygen therapy

Sponsor

Randy Trumbower, PT, PhD